VREX (Varex Imaging Corporation Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by VREX officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-15 | Shubham Maheshwari | Chief Financial Officer | MIXED | — | — |
| 2026-09-15 | Jay K. Kunkel | Director | Sell | — | — |
| 2026-08-18 | Karen L Aranki | Chief Human Resources Officer | MIXED | — | — |
| 2026-03-23 | Jay K. Kunkel | Director | Sell | — | — |
| 2026-02-13 | Jocelyn D Chertoff | Director | A | — | — |
| 2026-02-13 | Walter M Rosebrough Jr | Director | A | — | — |
| 2026-02-13 | Kathleen Bardwell | Director | A | — | — |
| 2026-02-13 | CHRISTINE A TSINGOS | Director | A | — | — |
| 2026-02-13 | TIMOTHY E GUERTIN | Director | A | — | — |
| 2026-02-13 | Jay K. Kunkel | Director | A | — | — |
| 2026-02-10 | Jay K. Kunkel | Director | M | — | — |
| 2026-02-09 | TIMOTHY E GUERTIN | Director | M | — | — |
| 2026-02-09 | Walter M Rosebrough Jr | Director | M | — | — |
| 2026-02-09 | Kathleen Bardwell | Director | M | — | — |
| 2026-02-09 | CHRISTINE A TSINGOS | Director | M | — | — |
| 2026-02-09 | Jocelyn D Chertoff | Director | M | — | — |
| 2025-12-17 | Karen L Aranki | Chief Human Resources Officer | A | — | — |
| 2025-12-17 | Shubham Maheshwari | Chief Financial Officer | A | — | — |
| 2025-12-17 | SUNNY SANYAL | President and CEO | A | — | — |
| 2025-12-17 | Andrew Hartmann | SVP and GM, Detectors | A | — | — |
| 2025-12-17 | Mark S. Jonaitis | SVP and GM, X-Ray Sources | A | — | — |
| 2025-12-12 | Karen L Aranki | Chief Human Resources Officer | MIXED | — | — |
| 2025-12-12 | Shubham Maheshwari | Chief Financial Officer | MIXED | — | — |
| 2025-12-12 | Mark S. Jonaitis | SVP and GM, X-Ray Sources | MIXED | — | — |
| 2025-12-12 | Andrew Hartmann | SVP and GM, Detectors | MIXED | — | — |
| 2025-12-12 | SUNNY SANYAL | President and CEO | MIXED | — | — |
| 2025-12-12 | Matthew Aaron Martinez | Chief Legal Officer | A | — | — |
| 2025-09-22 | Karen L Aranki | Chief Human Resources Officer | Sell | — | — |
| 2025-08-15 | Jay K. Kunkel | Director | Sell | — | — |
| 2025-06-20 | Jay K. Kunkel | Director | Sell | — | — |
| 2025-05-16 | Karen L Aranki | Chief Human Resources Officer | MIXED | — | — |
| 2025-05-16 | Shubham Maheshwari | Chief Financial Officer | MIXED | — | — |
| 2025-04-03 | SUNNY SANYAL | President and CEO | Sell | — | — |
| 2025-03-21 | Kimberley E. Honeysett | SVP and CLO | Sell | — | — |
| 2025-02-19 | Andrew Hartmann | SVP and GM, Detectors | MIXED | — | — |
| 2025-02-19 | Kimberley E. Honeysett | SVP and CLO | MIXED | — | — |
| 2025-02-19 | SUNNY SANYAL | President and CEO | MIXED | — | — |
| 2025-02-19 | Mark S. Jonaitis | SVP and GM, X-Ray Sources | MIXED | — | — |
| 2025-02-14 | Kathleen Bardwell | Director | M | — | — |
| 2025-02-14 | Walter M Rosebrough Jr | Director | M | — | — |
| 2025-02-14 | Jay K. Kunkel | Director | M | — | — |
| 2025-02-14 | Jocelyn D Chertoff | Director | M | — | — |
| 2025-02-14 | TIMOTHY E GUERTIN | Director | M | — | — |
| 2025-02-14 | CHRISTINE A TSINGOS | Director | M | — | — |
| 2024-12-18 | Karen L Aranki | Chief Human Resources Officer | A | — | — |
| 2024-12-18 | SUNNY SANYAL | President and CEO | A | — | — |
| 2024-12-18 | Mark S. Jonaitis | SVP and GM, X-Ray Sources | A | — | — |
| 2024-12-18 | Kimberley E. Honeysett | SVP and CLO | A | — | — |
| 2024-12-18 | Shubham Maheshwari | Chief Financial Officer | A | — | — |
| 2024-12-18 | Andrew Hartmann | SVP and GM, Detectors | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Chief Financial Officer | 269,972 | — |
| — | President and CEO | 216,845 | — |
| — | SVP and GM, X-Ray Sources | 74,932 | — |
| — | Director | 52,654 | — |
| — | Director | 42,655 | — |
| — | Director | 42,194 | — |
| — | SVP and GM, Detectors | 36,182 | — |
| — | Director | 29,846 | — |
| — | Director | 26,777 | — |
| — | Director | 24,948 | — |
| — | SVP & Chief Financial Officer | 24,434 | — |
| — | Director | 18,223 | — |
| — | SVP, Sales & Marketing | 16,816 | — |
| — | Director | 15,329 | — |
| — | Director | 12,102 | — |
| — | SVP and GM, X-ray Detectors | 8,342 | — |
| — | Chief Human Resources Officer | 7,748 | — |
| — | SVP and GM, X-Ray Detectors | 5,322 | — |
| — | SVP and CLO | 4,197 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the VREX quote page; the site-wide leaderboard is on the insider transactions hub.